Objectives

After participating in this educational activity, attendees should be able to:

1| Explain the purpose and historical context of the 340B Drug Pricing Program
2| Identify the eligibility criteria for covered entities and patients under the 340B program,
3| Describe the registration process and compliance requirements for participating entities
4| Identify the financial impact of the 340B program on healthcare organizations
5| Recognize key regulatory challenges, including duplicate discount prevention and HRSA audits
6| Identify ongoing legal and policy changes affecting 340B operations

Presenter(s): 
Karina Ponce, PharmD
PGY2 HSPAL Pharmacy Resident
Baystate Medical Center
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Karina Ponce, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
03/17/2025 - 2:00pm to 3:00pm EDT
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours

Please login or register to take this course.